Argenica Therapeutics Limited (ASX:AGN)
Australia
· Delayed Price · Currency is AUD 0.7000
+0.0050 (0.72%)
Jun 13, 2025, 2:42 PM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 89.27 million as of June 13, 2025. Its market cap has decreased by -6.21% in one year.
Market Cap
89.27M
Enterprise Value
74.19M
Revenue
3.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.70
Market Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has increased from 19.02M to 89.27M, an increase of 369.23%. That is a compound annual growth rate of 47.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 92.48M | 14.60% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 118.21B |
| Pro Medicus | 29.61B |
| Cochlear | 17.63B |
| Sonic Healthcare | 12.79B |
| Telix Pharmaceuticals | 8.78B |
| Ramsay Health Care | 8.55B |
| Ansell | 4.52B |
| Mesoblast | 2.38B |